API | peginterferon lambda-1a

peginterferon lambda-1a Report issue

Biologics Recombinant protein Experimental

AACT ChEMBL

Active Ingredient History

NOW

Now

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
peginterferon lambda-1a

More Chemistry

Pharmacology

Mechanisms of Action:
- Interferon lambda receptor 1 (Homo sapiens) ^UniProt
- Interleukin-10 receptor subunit beta (Homo sapiens) ^UniProt
Multi-specific: No
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

hdv-interferon | peg-il-29 | peg interferon lambda | peginterferon lambda | peginterferon lambda-1a | peg-ril-29 | pegylated interferon lambda | pegylated-interferon-lambda | pegylated interferon lambda-1a | pegylated recombinant interleukin 29

Organizations (23)

Research & Development (23)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (13)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (13)

COVID-19 (Phase 3)

Hepacivirus (Phase 3)

Hepatitis B, Chronic (Phase 1)

Hepatitis B virus (Phase 2)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Hepatitis D (Phase 2)

Hepatitis D, Chronic (Phase 2)

Hepatitis Delta Virus (Phase 3)

Liver Diseases (Phase 2)

Respiratory Syncytial Virus Infections (Phase 1/Phase 2)

SARS-CoV-2 (Phase 2)

Severe acute respiratory syndrome-related coronavirus (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 30
# of Trial Organizations: 23

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue